Peregrine Asset Advisers’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.05M | Buy |
2,901
+100
| +4% | +$34.2K | 0.23% | 91 |
|
|
2026
Q1 | $986K | Sell |
2,801
-12,872
| -82% | -$4.59M | 0.27% | 84 |
|
|
2025
Q4 | $5.13M | Buy |
15,673
+13,173
| +527% | +$4.18M | 1.45% | 25 |
|
|
2025
Q3 | $706K | Sell |
2,500
-300
| -11% | -$87K | 0.21% | 93 |
|
|
2025
Q2 | $726K | Buy |
2,800
+100
| +4% | +$28.3K | 0.23% | 88 |
|
|
2025
Q1 | $841K | Sell |
2,700
-2,000
| -43% | -$591K | 0.31% | 78 |
|
|
2024
Q4 | $1.23M | Buy |
4,700
+200
| +4% | +$59.3K | 0.45% | 59 |
|
|
2024
Q3 | $1.45M | Hold |
4,500
| – | – | 0.5% | 62 |
|
|
2024
Q2 | $1.41M | Hold |
4,500
| – | – | 0.55% | 50 |
|
|
2024
Q1 | $1.28M | Buy |
4,500
+1,000
| +29% | +$293K | 0.51% | 50 |
|
|
2023
Q4 | $1.01M | Buy |
3,500
+700
| +25% | +$191K | 0.49% | 62 |
|
|
2023
Q3 | $753K | Buy |
+2,800
| New | +$699K | 0.39% | 65 |
|
|
2020
Q3 | – | Sell |
-1,500
| Closed | -$354K | – | 95 |
|
|
2020
Q2 | $354K | Hold |
1,500
| – | – | 0.2% | 69 |
|
|
2020
Q1 | $304K | Sell |
1,500
-75
| -5% | -$16.4K | 0.23% | 59 |
|
|
2019
Q4 | $380K | Buy |
+1,575
| New | +$347K | 0.09% | 75 |
|
|
2018
Q4 | – | Sell |
-2,167
| Closed | -$449K | – | 75 |
|
|
2018
Q3 | $449K | Hold |
2,167
| – | – | 0.2% | 71 |
|
|
2018
Q2 | $400K | Hold |
2,167
| – | – | 0.21% | 71 |
|
|
2018
Q1 | $369K | Sell |
2,167
-2,383
| -52% | -$437K | 0.24% | 63 |
|
|
2017
Q4 | $791K | Buy |
4,550
+10
| +0.2% | +$1.77K | 0.4% | 46 |
|
|
2017
Q3 | $846K | Sell |
4,540
-960
| -17% | -$170K | 0.45% | 41 |
|
|
2017
Q2 | $947K | Hold |
5,500
| – | – | 0.6% | 33 |
|
|
2017
Q1 | $902K | Hold |
5,500
| – | – | 0.49% | 32 |
|
|
2016
Q4 | $804K | Hold |
5,500
| – | – | 0.48% | 41 |
|
|
2016
Q3 | $917K | Hold |
5,500
| – | – | 0.58% | 39 |
|
|
2016
Q2 | $837K | Hold |
5,500
| – | – | 0.56% | 44 |
|
|
2016
Q1 | $825K | Sell |
5,500
-200
| -4% | -$29.7K | 0.63% | 41 |
|
|
2015
Q4 | $925K | Sell |
5,700
-27,325
| -83% | -$4.3M | 0.8% | 33 |
|
|
2015
Q3 | $4.57M | Buy |
33,025
+27,525
| +500% | +$4.34M | 4.66% | 8 |
|
|
2015
Q2 | $844K | Hold |
5,500
| – | – | 0.63% | 30 |
|
|
2015
Q1 | $879K | Hold |
5,500
| – | – | 0.58% | 44 |
|
|
2014
Q4 | $876K | Hold |
5,500
| – | – | 0.62% | 46 |
|
|
2014
Q3 | $773K | Hold |
5,500
| – | – | 0.64% | 44 |
|
|
2014
Q2 | $651K | Hold |
5,500
| – | – | 0.59% | 48 |
|
|
2014
Q1 | $678K | Hold |
5,500
| – | – | 0.52% | 47 |
|
|
2013
Q4 | $627K | Hold |
5,500
| – | – | 0.55% | 40 |
|
|
2013
Q3 | $616K | Hold |
5,500
| – | – | 0.59% | 39 |
|
|
2013
Q2 | $543K | Buy |
+5,500
| New | +$571K | 0.56% | 42 |
|
Other funds holding AMGN
Peregrine Asset Advisers's AMGN Position: Q2 2026 in Review
Peregrine Asset Advisers increased its Amgen (AMGN) stake by 3.6% in Q2 2026, buying an estimated $34.2K and bringing the position to 2,901 shares worth $1.05M. The position accounts for 0.23% of the portfolio, ranked #91.
Peregrine Asset Advisers first reported a position in AMGN in Q2 2013 and has held it in 37 quarters since. The position peaked at $5.13M in Q4 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Peregrine Asset Advisers held 2,901 shares of Amgen worth $1.05M as of Q2 2026.
- Peregrine Asset Advisers bought 100 Amgen shares in Q2 2026, an estimated $34.2K.
- Amgen made up 0.23% of Peregrine Asset Advisers's portfolio in Q2 2026, its #91 holding.
- Peregrine Asset Advisers first reported a position in Amgen in Q2 2013 and has held it in 37 quarters since.
- Peregrine Asset Advisers's Amgen position peaked at $5.13M in Q4 2025.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Peregrine Asset Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.